The disclosure provides a simple and effective methods for sterilization of milk without degradation or loss of biologically active agents in the milk and the products produced by such methods.

A colostrum solid extraction process utilizes rennet coagulation prior to pH adjustment to alter the protein profile resulting in an animal feed supplement which enhances feed efficiency and general health. Rennet coagulation is used to produce extracted whey from colostrum. A pH of the extracted whey is adjusted by cooling the extracted whey to below 70 degrees Fahrenheit, adding an first solution to lower the pH of the extracted whey to 4.2 pH, adding a second solution to lower the pH of the extracted whey to 2.5 pH, agitating the extracted whey after reaching 2.5 pH, resting the extracted whey after agitation, and adding a third solution to raise the pH of the extracted whey to 4.2 pH.

Provided are compositions and methods for treating, ameliorating and preventing various infections, disorders and conditions in mammals, including genetically-predisposed and chronic disorders, where a microbial or bacterial flora is at least one causative or symptom-producing factor, where exemplary compositions are products of manufacture, a food, a drink, a nutraceutical, a dietary supplement, a formulation, a pharmaceutical or a pharmaceutical preparation comprising at least one or several of: a plurality of isolated, or substantially purified bacteriophages or prophages, or bacteriophage subunits, a milk, a milk product, milk lipid, milk fat globule (MFG) macromolecule, a milk mucin, a milk glycolipid, a milk free glycan, a milk mucin-like glycoprotein, a milk protein, a milk sugar or lactose, a milk fat or butterfat, a milk vitamin. In alternative embodiment, provided are compositions and methods for treating, preventing or ameliorating an infection, for example, an infection in the gastrointestinal tract, or bowel.

This disclosure describes compositions and methods for preventing and/or treating necrotizing enterocolitis (NEC) and preventing loss of intestinal integrity and/or improving intestinal integrity in neonatal subjects. Compositions useful in the methods of the disclosure comprise diamine oxidase (DAO) which can be from any source and formulated for systemic administration.

A flexible and collapsible liquid storage bag comprising front and back walls formed from a sheet material is described wherein a front wall and a back wall are joined along a perimeter of the bag and are also joined at a joined center portion proximate the centers of the respective front and back sheets. The bags are typically used in the storage, heat-treatment and dispensing of bovine colostrum.

Disclosed are thickener compositions composed of xanthan gum and a chelating agent, such as ascorbic acid. The chelating agent is present in an amount with respect to said xanthan such that, when said thickener composition is used to thicken a food product, at least one mineral selected from the group consisting of iron, zinc, and calcium present in said food product is relatively more bioavailable than the mineral would be in the absence of said chelating agent. The thickener composition finds particular applicability for use with baby formulas and breast milk intended for dysphagic infants. Also disclosed are baby formulas and thickened breast milk formulations, methods for preparing same, and methods for providing nutrition.

An object of the present invention is to provide a method of preparing an enzyme-treated bovine colostrum, comprising a step of bringing a bovine colostrum into contact with -galactosidase, and a pharmaceutical composition comprising the enzyme-treated bovine colostrum. The enzyme-treated bovine colostrum is useful for treatment, prevention, amelioration and maintenance of remission of diseases such as a cancer and an infectious disease.

The present disclosure relates to human milk compositions and methods of making and using the same. In particular, the disclosure features methods of using human milk compositions to feed subjects before and/or after surgery or medical operations and that are useful in promoting recovery.

A system includes memory banks that store data and a data path coupled to the memory banks that transfers the data. The system also includes a latch that gates the data path based on a clock signal in the system. The system further includes interface circuitry coupled to the data path that sends an instruction to the memory banks to transmit the data on the data path in response to receiving a first rising edge of the clock signal. The interface circuitry also outputs gated data in response to receiving a second rising edge of the clock signal. The latch gates the data path to store the gated data in response to receiving a falling edge of the clock signal.

The disclosure features human milk fortifier compositions, standardized human milk, and methods of making and using same. In one embodiment, a pasteurized human milk composition includes a human protein constituent of about 35-85 mg/mL; a human fat constituent of about 60-110 mg/mL; and a human carbohydrate constituent of about 60-140 mg/mL.